Phase II Study of QL1706 Combined With Paclitaxel and Bevacizumab for Second-Line Immune Rechallenge in Gastric Cancer
Clinical trial NCT07045805 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07045805
- Sponsor
- The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-25
- Primary completion
- 2027-07-31
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.